F. Hoffmann-La Roche Ltd. v. Empagran S.A., 542 U.S. 155 (2004) (U.S. Supreme Court)
Empagran is a cornerstone case on the reach of U.S. antitrust laws to foreign conduct and foreign injuries.
Under the FTAIA, may foreign purchasers who suffered injury abroad from a worldwide price-fixing conspiracy bring Sherman Act claims in U.S. courts based solely on the conspiracy's domestic effects on U.S. commerce, even though their injuries are independent of those domestic effects?
The FTAIA, 15 U.S.C. § 6a, provides that the Sherman Act does not apply to non-import foreign commerce unless (1) the conduct has a direct, substantial, and reasonably foreseeable effect on U.S. domestic, import, or certain export commerce, and (2) that domestic effect gives rise to the plaintiff's claim under the antitrust laws. The statutory phrase "gives rise to" requires a proximate causal relationship between the domestic effect and the particular plaintiff's injury; a foreign plaintiff injured abroad cannot sue under the Sherman Act where the foreign injury is independent of any domestic effect. Principles of international comity support this narrow construction.
No. The FTAIA bars foreign purchasers' Sherman Act claims for injuries suffered abroad when those injuries are independent of any domestic effect; the statute requires that the U.S. effect proximately cause the plaintiff's claim.
Empagran is the leading case on the FTAIA's "gives rise to" requirement and the extraterritorial scope of U.S. antitrust law. It substantially narrows the path for foreign purchasers to bring treble-damages claims in U.S. courts for injuries suffered abroad, requiring a proximate causal link between a domestic effect and the plaintiff's injury. For practitioners and students, the case underscores the importance of pleading and proof focused on plaintiff-specific causation, the distinction between import commerce and other foreign commerce, and the central role of comity in transnational antitrust enforcement. Empagran also shapes global cartel litigation strategy, often forcing foreign-injury claims to be litigated in non-U.S. fora or to be tethered tightly to U.S. effects.